Sims Andrew John Hugh MacIntyre, CFO of Plus Therapeutics, Inc. ($PSTV), made one open market purchase of common shares in the last year, totaling $10,200, with the most recent on November 4, 2025. This ranks 4,256th among nearly 5,000 insiders in our database, where the average buy amounts to $1.46 million across about 3.3 transactions. He reported no open market sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| April 1, 2026 | PLUS THERAPEUTICS, INC. | $PSTV | Sims Andrew John Hugh MacIntyre | Chief Financial Officer | M | Restricted Stock Units | 29129 | $0.00 | 665,322.0000 | 137,429,055 | 4.19% | 0.02% |
| April 1, 2026 | PLUS THERAPEUTICS, INC. | $PSTV | Sims Andrew John Hugh MacIntyre | Chief Financial Officer | M | Restricted Stock Units | 38323 | $0.00 | 694,451.0000 | 137,429,055 | 5.23% | 0.03% |
| April 1, 2026 | PLUS THERAPEUTICS, INC. | $PSTV | Sims Andrew John Hugh MacIntyre | Chief Financial Officer | M | Common Stock | 29129 | $0.00 | 173,913.0000 | 137,429,055 | 20.12% | 0.02% |
| April 1, 2026 | PLUS THERAPEUTICS, INC. | $PSTV | Sims Andrew John Hugh MacIntyre | Chief Financial Officer | M | Common Stock | 38323 | $0.00 | 144,784.0000 | 137,429,055 | 36.00% | 0.03% |
| Feb. 25, 2026 | PLUS THERAPEUTICS, INC. | $PSTV | Sims Andrew John Hugh MacIntyre | Chief Financial Officer | A | Restricted Stock Units | 349542 | $0.00 | 732,774.0000 | 137,429,055 | 91.21% | 0.25% |
| Feb. 25, 2026 | PLUS THERAPEUTICS, INC. | $PSTV | Sims Andrew John Hugh MacIntyre | Chief Financial Officer | A | Stock Option (Right to Buy) | 349541 | $0.00 | 349,541.0000 | 137,429,055 | 9999.99% | 0.25% |
| Jan. 1, 2026 | PLUS THERAPEUTICS, INC. | $PSTV | Sims Andrew John Hugh MacIntyre | Chief Financial Officer | M | Restricted Stock Units | 38323 | $0.00 | 383,232.0000 | 137,429,055 | 9.09% | 0.03% |
| Jan. 1, 2026 | PLUS THERAPEUTICS, INC. | $PSTV | Sims Andrew John Hugh MacIntyre | Chief Financial Officer | M | Common Stock | 38323 | $0.00 | 106,461.0000 | 137,429,055 | 56.24% | 0.03% |
| Nov. 4, 2025 | PLUS THERAPEUTICS, INC. | $PSTV | Sims Andrew John Hugh MacIntyre | Chief Financial Officer | P | Common Stock | 20000 | $0.51 | 68,138.0000 | 137,429,055 | 41.55% | 0.01% |
| Oct. 1, 2025 | PLUS THERAPEUTICS, INC. | $PSTV | Sims Andrew John Hugh MacIntyre | Chief Financial Officer | M | Restricted Stock Units | 38323 | $0.00 | 421,555.0000 | 16,999,626 | 8.33% | 0.23% |
| Oct. 1, 2025 | PLUS THERAPEUTICS, INC. | $PSTV | Sims Andrew John Hugh MacIntyre | Chief Financial Officer | M | Common Stock | 38323 | $0.00 | 48,138.0000 | 16,999,626 | 390.45% | 0.23% |
| Aug. 13, 2025 | PLUS THERAPEUTICS, INC. | $PSTV | Sims Andrew John Hugh MacIntyre | Chief Financial Officer | A | Stock Option (Right to Buy) | 1379636 | $0.00 | 1,379,636.0000 | 16,999,626 | 9999.99% | 8.12% |
| Aug. 13, 2025 | PLUS THERAPEUTICS, INC. | $PSTV | Sims Andrew John Hugh MacIntyre | Chief Financial Officer | A | Restricted Stock Units | 459878 | $0.00 | 459,878.0000 | 16,999,626 | 9999.99% | 2.71% |
| Aug. 13, 2025 | PLUS THERAPEUTICS, INC. | $PSTV | Sims Andrew John Hugh MacIntyre | Chief Financial Officer | A | Stock Option (Right to Buy) | 1379636 | $0.00 | 1,379,636.0000 | 16,999,626 | 9999.99% | 8.12% |
| Aug. 13, 2025 | PLUS THERAPEUTICS, INC. | $PSTV | Sims Andrew John Hugh MacIntyre | Chief Financial Officer | A | Restricted Stock Units | 459878 | $0.00 | 459,878.0000 | 16,999,626 | 9999.99% | 2.71% |
| Feb. 18, 2025 | PLUS THERAPEUTICS, INC. | $PSTV | Sims Andrew John Hugh MacIntyre | Chief Financial Officer | A | Stock Option (Right to Buy) | 60020 | $0.00 | 60,020.0000 | 0 | 9999.99% | 0.00% |
| Sept. 11, 2024 | PLUS THERAPEUTICS, INC. | $PSTV | Sims Andrew John Hugh MacIntyre | Chief Financial Officer | A | Stock Option (Right to Buy) | 46074 | $0.00 | 46,074.0000 | 0 | 9999.99% | 0.00% |
| Sept. 10, 2024 | PLUS THERAPEUTICS, INC. | $PSTV | Sims Andrew John Hugh MacIntyre | Chief Financial Officer | P | Common Stock | 4098 | $1.27 | 9,815.0000 | 0 | 71.68% | 0.00% |
| May 8, 2024 | PLUS THERAPEUTICS, INC. | $PSTV | Sims Andrew John Hugh MacIntyre | Chief Financial Officer | A | Warrants (Right to buy) | 9804 | $0.00 | 9,804.0000 | 0 | 9999.99% | 0.00% |
| May 8, 2024 | PLUS THERAPEUTICS, INC. | $PSTV | Sims Andrew John Hugh MacIntyre | Chief Financial Officer | P | Common Stock | 4902 | $2.04 | 5,717.0000 | 0 | 601.47% | 0.00% |
| Feb. 22, 2024 | PLUS THERAPEUTICS, INC. | $PSTV | Sims Andrew John Hugh MacIntyre | Chief Financial Officer | A | Stock Option (Right to Buy) | 18933 | $0.00 | 18,933.0000 | 0 | 9999.99% | 0.00% |